Procter & Gamble Co. Faces Consumer‑Product Packaging Controversy
Legal Action Over Crest Toothpaste Packaging
On 11 November 2025, a group of parents filed a lawsuit against Procter & Gamble (NYSE: PG), alleging that the packaging of the company’s Crest toothpaste for children is misleading. The plaintiffs claim that the design and labeling may give consumers the impression that the product is suitable for use beyond the recommended age range, potentially endangering young users. The case has been reported by InsiderMonkey and is currently pending in the U.S. federal court system. Procter & Gamble has not yet issued a formal response to the allegations.
Investor Interest Near 52‑Week Low
In a separate development on 10 November 2025, congresswoman Marjorie Taylor Greene (R‑Ga.) disclosed a purchase of Procter & Gamble stock, acquiring shares near the company’s 52‑week low of $144.09. The transaction was reported by Benzinga and reflects Greene’s growing engagement in the equity markets, as she routinely files monthly disclosures of her trading activities. While the purchase amount was modest compared with her other holdings, it indicates continued institutional interest in PG shares despite recent regulatory scrutiny.
Company Overview
Procter & Gamble Co. is an American manufacturer and marketer of consumer products in the household‑products sector. The company’s portfolio spans laundry and cleaning, paper, beauty care, food and beverage, and health‑care categories. Its stock trades on the New York Stock Exchange under the ticker PG. As of 9 November 2025, the share price closed at $145.50. The firm’s 52‑week range is $144.09 (low) to $180.43 (high). Market capitalization stands at $343.5 billion, with a price‑earnings ratio of 21.12. The company’s website is us.pg.com.
Market Impact
The lawsuit could influence consumer perception and potentially lead to regulatory scrutiny of packaging standards for pediatric products. However, the market reaction has been muted, with the share price remaining within the current 52‑week range. The congressional purchase at a low point may be viewed as a confidence signal, but it has not yet translated into significant price movement. Investors will monitor both the legal proceedings and any subsequent regulatory actions to assess long‑term implications for Procter & Gamble’s product strategy and shareholder value.
